Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Thomas

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
British Journal of Nursing (Mark Allen Publishing)|June 1, 2022
Inequalities in cancer screening, prevention and service engagement between UK ethnic minority groupsShalin Abraham, Nalini Foreman, Zahirah Sidat, et al.
The Journal of Biological Chemistry|December 12, 2003
Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human kappa light chainsNicholas G Housden, Steven Harrison, Hazel R Housden, et al.
The Lancet. Oncology|April 18, 2014
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 studyTimothy J Price, Marc Peeters, Tae Won Kim, et al.
Journal for Immunotherapy of Cancer|December 17, 2025
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1Gary Middleton, Charlotte Gaskell, Joshua Savage, et al.
BMC Research Notes|July 2, 2011
Comparison of buccal and blood-derived canine DNA, either native or whole genome amplified, for array-based genome-wide association studiesGonzalo Rincon, Katarina Tengvall, Janelle M Belanger, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
A phase 2 study of vatalanib in metastatic melanoma patientsNatalie Cook, Bristi Basu, Swethajit Biswas, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2009
Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelinesStephanie K Brodine, Anne Thomas, Robert Huang, et al.
Plos Genetics|May 17, 2014
A mutation in the FAM83G gene in dogs with hereditary footpad hyperkeratosis (HFH)Michaela Drögemüller, Vidhya Jagannathan, Doreen Becker, et al.
Annals of Hematology|March 20, 2013
A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian populationVytautas Ivaskevicius, Arijit Biswas, Anne Thomas, et al.
Carcinogenesis|January 20, 2004
Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemicalEilish T Donnelly, Helen Bardwell, Geraldine Anne Thomas, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Nursing (Mark Allen Publishing)|June 1, 2022
Inequalities in cancer screening, prevention and service engagement between UK ethnic minority groupsShalin Abraham, Nalini Foreman, Zahirah Sidat, et al.
The Journal of Biological Chemistry|December 12, 2003
Observation and characterization of the interaction between a single immunoglobulin binding domain of protein L and two equivalents of human kappa light chainsNicholas G Housden, Steven Harrison, Hazel R Housden, et al.
The Lancet. Oncology|April 18, 2014
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 studyTimothy J Price, Marc Peeters, Tae Won Kim, et al.
Journal for Immunotherapy of Cancer|December 17, 2025
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1Gary Middleton, Charlotte Gaskell, Joshua Savage, et al.
BMC Research Notes|July 2, 2011
Comparison of buccal and blood-derived canine DNA, either native or whole genome amplified, for array-based genome-wide association studiesGonzalo Rincon, Katarina Tengvall, Janelle M Belanger, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2010
A phase 2 study of vatalanib in metastatic melanoma patientsNatalie Cook, Bristi Basu, Swethajit Biswas, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2009
Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelinesStephanie K Brodine, Anne Thomas, Robert Huang, et al.
Plos Genetics|May 17, 2014
A mutation in the FAM83G gene in dogs with hereditary footpad hyperkeratosis (HFH)Michaela Drögemüller, Vidhya Jagannathan, Doreen Becker, et al.
Annals of Hematology|March 20, 2013
A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian populationVytautas Ivaskevicius, Arijit Biswas, Anne Thomas, et al.
Carcinogenesis|January 20, 2004
Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemicalEilish T Donnelly, Helen Bardwell, Geraldine Anne Thomas, et al.
Pageof 14